-
-
[1]Peng GP, Li SP, Wu W, et al.PD-1upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients[J].Molecular Immunology, 2008, 45∶963-970. [1]Peng GP, Li SP, Wu W, et al.PD-1upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients[J].Molecular Immunology, 2008, 45∶963-970. [2]Ishida Y, Agata Y, Shibahara K, et a1.Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon pro-grammed cell death[J].EMBO J, 1992, 11∶3887-3890. [2]Ishida Y, Agata Y, Shibahara K, et a1.Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon pro-grammed cell death[J].EMBO J, 1992, 11∶3887-3890. [3]Freeman GJ, John E, Rafi A, et al.Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1ligand blockade[J].Exp Med, 2006, 203 (10) ∶2223-2227. [3]Freeman GJ, John E, Rafi A, et al.Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1ligand blockade[J].Exp Med, 2006, 203 (10) ∶2223-2227. [4]Dong HD, Zhu GF, Tamada K, et a1.B7-H1, a third member of the B7Family, co-stimulates T-cell proliferation and interleukin-10secretion[J].Nat Med, 1999, 5∶1365-1369. [4]Dong HD, Zhu GF, Tamada K, et a1.B7-H1, a third member of the B7Family, co-stimulates T-cell proliferation and interleukin-10secretion[J].Nat Med, 1999, 5∶1365-1369. [5]Latchman Y, Wood CR, Chernova T, et al.PD-L2is a second lig-and for PD-1and inhibits T cell activiation[J].Nat Immunol, 2001, 2 (3) ∶261-268. [5]Latchman Y, Wood CR, Chernova T, et al.PD-L2is a second lig-and for PD-1and inhibits T cell activiation[J].Nat Immunol, 2001, 2 (3) ∶261-268. [6]Carter L, Fouser LA, Jussif J, et al.PD-1:PD-Linhibitory path-way affects both CD4 (+) and CD8 (+) Tcells and is overcome by IL-2[J].Eur Immunol, 2002, 32 (3) ∶634-643. [6]Carter L, Fouser LA, Jussif J, et al.PD-1:PD-Linhibitory path-way affects both CD4 (+) and CD8 (+) Tcells and is overcome by IL-2[J].Eur Immunol, 2002, 32 (3) ∶634-643. [7]Lucy GM, Brent P, Jared K, et al.Upregulation of PD-1Expres-sion on Circulating and Intrahepatic Hepatitis C Virus-Specific CD8+TCells Associated with Reversible Immune Dysfunction[J].J Vi-rology, 2007, 81 (17) ∶9249-9258. [7]Lucy GM, Brent P, Jared K, et al.Upregulation of PD-1Expres-sion on Circulating and Intrahepatic Hepatitis C Virus-Specific CD8+TCells Associated with Reversible Immune Dysfunction[J].J Vi-rology, 2007, 81 (17) ∶9249-9258. [8]Holly M, Masanori I, Gordon J, et al.PD-1:PD-L1Interactions Contribute to the Functional Suppression of Virus-Specific CD8+T Lymphocytes in the Liver[J].J Immunology, 2007, 178:2714-2720. [8]Holly M, Masanori I, Gordon J, et al.PD-1:PD-L1Interactions Contribute to the Functional Suppression of Virus-Specific CD8+T Lymphocytes in the Liver[J].J Immunology, 2007, 178:2714-2720. [9]Brown Ja, Dorfman DM, Ma FR, et al.Blockade of Programmed Death-1Ligands on Dendritic Cells Enhances TCell Activation and Cytokine Production[J].J Immunology, 2003, 170∶1257-1266. [9]Brown Ja, Dorfman DM, Ma FR, et al.Blockade of Programmed Death-1Ligands on Dendritic Cells Enhances TCell Activation and Cytokine Production[J].J Immunology, 2003, 170∶1257-1266. [10]李永纲, 陈良恩, 陈国凤, 等.B7-H1及其受体PD-1在慢性乙型肝炎患者淋巴细胞上的表达及意义[J].中华肝脏病杂志, 2007, 15 (10) ∶738-741. [10]李永纲, 陈良恩, 陈国凤, 等.B7-H1及其受体PD-1在慢性乙型肝炎患者淋巴细胞上的表达及意义[J].中华肝脏病杂志, 2007, 15 (10) ∶738-741. [11]Chen LG, Zhang Z, Chen WW, et al.B7-H1Up-Regulation on Myeloid Dendritic Cells Significantly Suppresses T Cell Immune Function in Patients with Chronic Hepatitis B[J].J Immunology, 2007, 178∶6634-6641. [11]Chen LG, Zhang Z, Chen WW, et al.B7-H1Up-Regulation on Myeloid Dendritic Cells Significantly Suppresses T Cell Immune Function in Patients with Chronic Hepatitis B[J].J Immunology, 2007, 178∶6634-6641. [12]Xie ZY, Chen YW, Fu XL, et al.Expression of B7-H1on pe-ripheral blood mononuclear cells from chronic hepatitis B patients[J].Nan Fang Yi Ke Da Xue Xue Bao, 2007, 27 (11) ∶1635-1637. [12]Xie ZY, Chen YW, Fu XL, et al.Expression of B7-H1on pe-ripheral blood mononuclear cells from chronic hepatitis B patients[J].Nan Fang Yi Ke Da Xue Xue Bao, 2007, 27 (11) ∶1635-1637. [13]Keir ME, Liang SC, Guleria I, et al.Tissue expression of PD-L1mediates peripheral Tcell tolerance[J].JEM, 2003, (4) ∶883-895. [13]Keir ME, Liang SC, Guleria I, et al.Tissue expression of PD-L1mediates peripheral Tcell tolerance[J].JEM, 2003, (4) ∶883-895. [14]Natalia MO, Wang YH, Hideo Y, et al.Cutting Edge:Programed Death (PD) Ligand-1/PD-1Interaction Is Required for CD8+T Cell Tolerance to Tissue Antigens[J].J Immunology, 2006, 177∶8291-8295. [14]Natalia MO, Wang YH, Hideo Y, et al.Cutting Edge:Programed Death (PD) Ligand-1/PD-1Interaction Is Required for CD8+T Cell Tolerance to Tissue Antigens[J].J Immunology, 2006, 177∶8291-8295. [15]Mühlbauer M, Fleck M, Schütz C, et al.PD-L1is induced in hepatocytes by viral infection and by interferon-alpha and-gamma and mediates Tcell apoptosis[J].J Hepatol, 2006, 45 (4) ∶520-528. [15]Mühlbauer M, Fleck M, Schütz C, et al.PD-L1is induced in hepatocytes by viral infection and by interferon-alpha and-gamma and mediates Tcell apoptosis[J].J Hepatol, 2006, 45 (4) ∶520-528. [16]Geng L, Jiang G, Fang Y, et al.B7-H1expression is upregulat-ed in peripheral blood CD14+monocytes of patients with chronic hepatitis B virus infection, which correlates with higher serum IL-10levels[J].J viral Hepat, 2006, 13 (11) ∶725-733. [16]Geng L, Jiang G, Fang Y, et al.B7-H1expression is upregulat-ed in peripheral blood CD14+monocytes of patients with chronic hepatitis B virus infection, which correlates with higher serum IL-10levels[J].J viral Hepat, 2006, 13 (11) ∶725-733. [17]Diehl L, Schurich A, Grochtmann R, et al.Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog1-de-pendent CD8+T cell tolerance[J].Hepatology, 2008, 47 (1) ∶296-305. [17]Diehl L, Schurich A, Grochtmann R, et al.Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog1-de-pendent CD8+T cell tolerance[J].Hepatology, 2008, 47 (1) ∶296-305. [18]Yoshiko I, Seigo T, Masaya I, et al.PD-1Inhibits Antiviral Im-munity at the Effector Phase in the Liver[J].J Experimental Medi-cine, 2003, 198 (1) ∶39-50. [18]Yoshiko I, Seigo T, Masaya I, et al.PD-1Inhibits Antiviral Im-munity at the Effector Phase in the Liver[J].J Experimental Medi-cine, 2003, 198 (1) ∶39-50.
本文二维码
计量
- 文章访问数: 2055
- HTML全文浏览量: 2
- PDF下载量: 1166
- 被引次数: 0